申请人:Riker Laboratories, Inc.
公开号:US04567269A1
公开(公告)日:1986-01-28
5-isothiocyanato-2-methylquinolines, N-(2,2-dialkoxyethyl)-N'-(2-methylquinolin-5-yl)thioureas, 5-(2-mercaptoimidazol-1-yl)-2-methylquinolines, 5-(imidazol-1-yl)-2-methylquinolines, 5-(imidazol-1-yl)-1,2,3,4-tetrahydro-2-methylquinolines and dialkoxy 2-[N-(5-(imidazol-1-yl)-1,2,3,4-tetrahydro-2-methylquinolinyl)]methylenema lonates are described as intermediates for antimicrobial 6,7-dihydro-8-(imidazol-1-yl)-5-methyl-1-oxo-1H,5H-benzo[ij]quinolizine-2- carboxylic acids.
5-异硫氰酸基-2-甲基喹啉,N-(2,2-二烷氧基乙基)-N'-(2-甲基喹啉-5-基)硫脲,5-(2-巯基咪唑-1-基)-2-甲基喹啉,5-(咪唑-1-基)-2-甲基喹啉,5-(咪唑-1-基)-1,2,3,4-四氢-2-甲基喹啉和二烷氧基2-[N-(5-(咪唑-1-基)-1,2,3,4-四氢-2-甲基喹啉基)]甲酸酯被描述为抗微生物6,7-二氢-8-(咪唑-1-基)-5-甲基-1-氧代-1H,5H-苯并[ij]喹啉-2-羧酸的中间体。